Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in Cardiac Surgery
NCT00166127Phase 3Terminated
- Sponsor
- Emory University
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levosimendan in heart failure (HF), sponsored by Emory University. Started May 2005; status: terminated.
02
Drugs
levosimendan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00166127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00166127.